A Classic Ketogenic Diet as a Complementary Therapeutic Management on Patients With High-grade Gliomas and Brain Metastases.
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The survival interval of patients with gliomas ranges between 12 to 15 months. Recent findings revealed that dietary interventions to reduce glucose and glycolytic pathways could have a therapeutic effect. Ketosis can be an effective therapy to extend the survival of patients with gliomas.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Age 18-80
• Karnofsky Performance Score of 50 or more.
• Newly diagnosed, histologically confirmed glioblastoma grade 4, or secondary metastases or progression after surgical resection, radiation and chemotherapy.
• Normal function of liver and kidneys
• Ability to sign informed consent form
Locations
Other Locations
Greece
Attikon University General Hospital
RECRUITING
Athens
Arezina Kasti
RECRUITING
Chaïdári
Contact Information
Primary
Arezina N. Kasti, RD
kastiare@yahoo.gr
+306942917860
Backup
Evangelos K. Papadopoulos, MD
neuroevan@yahoo.gr
6936251274
Time Frame
Start Date: 2022-09-20
Estimated Completion Date: 2026-02-28
Participants
Target number of participants: 15
Treatments
Experimental: Classic Ketogenic Diet
Patients will adhere to a classic ketogenic diet for a period of 3 months with a possible extension depending on their compliance on the diet.
Related Therapeutic Areas
Sponsors
Leads: Attikon Hospital